These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34187598)

  • 41. miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma.
    Xie F; Yuan Y; Xie L; Ran P; Xiang X; Huang Q; Qi G; Guo X; Xiao C; Zheng S
    Onco Targets Ther; 2017; 10():885-894. PubMed ID: 28243124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-30a-5p suppresses proliferation, invasion and tumor growth of hepatocellular cancer cells via targeting FOXA1.
    Zhang S; Liu Q; Zhang Q; Liu L
    Oncol Lett; 2017 Oct; 14(4):5018-5026. PubMed ID: 29085515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Downregulation of circDYNC1H1 exhibits inhibitor effect on cell proliferation and migration in hepatocellular carcinoma through miR-140-5p.
    Wang ZY; Zhu Z; Wang HF; Qin B; Liu J; Yao XH; Li WC; Chen KS
    J Cell Physiol; 2019 Aug; 234(10):17775-17785. PubMed ID: 30864145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
    Wang YG; Wang T; Shi M; Zhai B
    J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of miR-18a-5p as an oncogene and prognostic biomarker in RCC.
    Zhou L; Li Z; Pan X; Lai Y; Quan J; Zhao L; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Lai Y
    Am J Transl Res; 2018; 10(6):1874-1886. PubMed ID: 30018727
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-488 suppresses cell proliferation and invasion by targeting ADAM9 and lncRNA HULC in hepatocellular carcinoma.
    Hu D; Shen D; Zhang M; Jiang N; Sun F; Yuan S; Wan K
    Am J Cancer Res; 2017; 7(10):2070-2080. PubMed ID: 29119055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Good or not good: Role of miR-18a in cancer biology.
    Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K
    Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Urothelial carcinoma-associated 1 enhances tamoxifen resistance in breast cancer cells through competitively inhibiting miR-18a].
    Li XN; Liu AH; Tang X; Ren Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 49(2):295-302. PubMed ID: 28416841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis.
    Ding Z; Guo L; Deng Z; Li P
    Ann Hepatol; 2020; 19(3):269-279. PubMed ID: 32089501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LncRNA RUNX1-IT1 is downregulated in gastric cancer and suppresses the maturation of miR-20a by binding to its precursor.
    Bao L; Du B; Guo Y; Zhang H; Mao Z
    Histol Histopathol; 2023 Nov; 38(11):1321-1326. PubMed ID: 36722424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
    Zhao J; Xu T; Wang F; Cai W; Chen L
    Biomed Pharmacother; 2017 Jun; 90():744-751. PubMed ID: 28419971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circular RNA profiling identifies circADAMTS13 as a miR-484 sponge which suppresses cell proliferation in hepatocellular carcinoma.
    Qiu L; Huang Y; Li Z; Dong X; Chen G; Xu H; Zeng Y; Cai Z; Liu X; Liu J
    Mol Oncol; 2019 Feb; 13(2):441-455. PubMed ID: 30537115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long noncoding RNA GAS5 suppresses the migration and invasion of hepatocellular carcinoma cells via miR-21.
    Hu L; Ye H; Huang G; Luo F; Liu Y; Liu Y; Yang X; Shen J; Liu Q; Zhang J
    Tumour Biol; 2016 Feb; 37(2):2691-702. PubMed ID: 26404135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells.
    He J; Zhao K; Zheng L; Xu Z; Gong W; Chen S; Shen X; Huang G; Gao M; Zeng Y; Zhang Y; He F
    Mol Cancer; 2015 Aug; 14():163. PubMed ID: 26302777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long noncoding RNA GAS5 regulates the proliferation, migration, and invasion of glioma cells by negatively regulating miR-18a-5p.
    Liu Q; Yu W; Zhu S; Cheng K; Xu H; Lv Y; Long X; Ma L; Huang J; Sun S; Wang K
    J Cell Physiol; 2018 Jan; 234(1):757-768. PubMed ID: 30078184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.
    Long J; Jiang C; Liu B; Fang S; Kuang M
    Tumour Biol; 2016 May; 37(5):5821-8. PubMed ID: 26581909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retracted Article: lncRNA TINCR sponges miR-214-5p to upregulate ROCK1 in hepatocellular carcinoma.
    Hu M; Han Y; Zhang Y; Zhou Y; Ye L
    BMC Med Genet; 2020 Jan; 21(1):2. PubMed ID: 31900116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of miR-18a on proliferation and apoptosis of gastric cancer cells by regulating RUNX1.
    Qi B; Dong Y; Qiao XL
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9957-9964. PubMed ID: 33090400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CCAT2 contributes to hepatocellular carcinoma progression via inhibiting miR-145 maturation to induce MDM2 expression.
    Niu C; Wang L; Ye W; Guo S; Bao X; Wang Y; Xia Z; Chen R; Liu C; Lin X; Huang X
    J Cell Physiol; 2020 Sep; 235(9):6307-6320. PubMed ID: 32037568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.
    Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J
    BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.